What happened
SK biopharmaceuticals disclosed a supply contract with SK Life Science,Inc., worth US$27.7M, about 5.9% of its recent annual revenue, running through May 2026.
For context, this single contract equals about 5.9% of the company's most recent annual revenue.
| Counterparty | SK Life Science,Inc. |
|---|---|
| Contract value | US$27.7M |
| vs. recent revenue | 5.9% |
| Through | May 2026 (from May 2026) |
| Filed | 2026-05-27, Supply contract signed |
| Source | DART rcept 20260527800495 → open original filing |
Source: DART. Information only, not investment advice.